[Incidence and mortality of uterine cervix cancer in Norway. When do we get organized nation-wide cytologic screening in Norway?].
In 1975 and 1985 the Norwegian Ministry of Health appointed a committee to evaluate the value of cytological examination of the uterine cervix in Norway. Both committees recommended that all Norwegian women aged 20/25 to 69 should be examined every three years. The reduction in incidence of cervical cancer and the mortality from the disease has been very slight compared to the reduction in the other Nordic countries where, in contrast to Norway, organized screening has been carried out on a large scale. There are no objections to an immediate organization of a national screening programme in Norway, either from the medical or the economic point of view.
Magnus
K
K
Kreftregisteret Montebello, Oslo.
Langmark
F
F
D000328:Adult; D000368:Aged; D003584:Cytological Techniques; D005260:Female; D006801:Humans; D015994:Incidence; D008403:Mass Screening / Q000458:organization & administration; D008875:Middle Aged; D009664:Norway / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology; D014626:Vaginal Smears
Insidens og mortalitet av livmorhalskreft i Norge. Når får vi en organisert landsomfattende cytologisk screening i Norge?